Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and ...

Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection ...

In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

How effective is nirsevimab at preventing respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD), ...

The Public Health Department's improved dashboard includes data on real-time spread and vaccination rates for the three ...

The move comes just weeks after the CDC officially accepted recommendations to stop giving newborns the hepatitis B vaccine ...

Six routine vaccines that have safeguarded millions from serious diseases are no longer being recommended for all children by the CDC.

Report Ocean’s comprehensive analysis delves into the Respiratory Syncytial Virus (RSV) landscape, encompassing historical data, forecasted epidemiology, and market trends globally. The report ...

The New Lenox hospital detailed how many they've seen for flu and respiratory illnesses, noting 100 of those have been ...